13 Oct The American Journal of Tropical Medicine and Hygiene publishes a research article on the Malaria Vaccination Initiative in Equatorial Guinea
The prestigious scientific publication “American Journal of Tropical Medicine and Hygiene” has published a scientific article on the Equatorial Guinea Malaria Vaccination Initiative (EGMVI). The letter describes the work carried out in the development of a vaccine against malaria and the interest of the Government of Equatorial Guinea in implementing the vaccine against the Plasmodium falciparum sporozoite (PfSPZ) from Sanaria to eliminate Plasmodium falciparum (Pf) malaria in certain regions. selected.
EGMVI is a project that starts from the launch of a scientific research platform and that has become the planning of the elimination of Malaria in Central and West Africa. As explained in the published article, a vaccine with a “massive effect” (herd immunity) would be an ideal tool, together with the implementation of other control measures, to achieve the elimination of malaria. “PfSPZ vaccines have a proven track record of preventing Pf infections, in controlled human malaria infection (CHMI) studies and naturally transmitted settings, and are among the most advanced malaria vaccine candidates,” the publication explains. .
The authors of the scientific article anticipate that, next year, the Government, the Bioko Island Malaria Elimination Program (BIMEP), Marathon Oil, Noble Energy and Atlantic Methanol Production Company and EGMVI will start the third phase of the vaccine with a clinical trial involving 2,100 Equatorial Guineans to obtain the necessary data for the authorization of the Sanaria® PfSPZ vaccine.
To find out more, click on this link (https://guineasalud.org/scientific-publications/?lang=en)